BARDA
Pattern Bioscience Wins BARDA Contract Worth up to $40.9M
The contract's base award is $22.5 million, which Pattern said will support the late-stage development of its single-cell microbiology ID and AST system.
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
Both firms will develop rapid, home-use diagnostic tests to simultaneously detect SARS-CoV-2, influenza A, and influenza B.
BARDA Initiatives Award Approximately $2.8M to Four Diagnostics Developers
The contracts were awarded to Karius, Signature Science, In Diagnostics, and Tufts University through BARDA's Agnostic Diagnostics and Lab at Home initiatives.
BugSeq Wins BARDA Contract to Develop AI Tools for Metagenomic Pathogen Sequencing
The company said it will be developing the tools with an eye toward regulatory compliance and their use in real-world settings.
Cue Health Awarded $28M BARDA Contract to Develop Multiplex Respiratory Test
The molecular test would detect and differentiate among influenza A/B, respiratory syncytial virus, and COVID-19 and deliver results within 25 minutes.
Jul 30, 2021
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
May 6, 2021
T2 Biosystems Q1 Revenues Nearly Triple
Apr 26, 2021